H.R.758 - Pediatric Research Consortia Establishment Act111th Congress (2009-2010)
|Sponsor:||Rep. DeGette, Diana [D-CO-1] (Introduced 01/28/2009)|
|Committees:||House - Energy and Commerce | Senate - Health, Education, Labor, and Pensions|
|Committee Reports:||H. Rept. 111-640|
|Latest Action:||11/15/2010 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.|
This bill has the status Passed House
Here are the steps for Status of Legislation:
- Passed House
Summary: H.R.758 — 111th Congress (2009-2010)All Bill Information (Except Text)
Passed House amended (09/30/2010)
(This measure has not been amended since it was reported to the House on September 28, 2010. The summary of that version is repeated here.)
Pediatric Research Consortia Establishment Act - Amends the Public Health Service Act to authorize the Director of the National Institutes of Health (NIH), acting through the Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, to award grants, contracts, or cooperative agreements to public or nonprofit private entities to pay all or part of the cost of planning, establishing, and providing basic operating support for up to 20 national pediatric research consortia. Requires the Director of NIH to take unmet research needs into account when making awards under this Act.
Declares that research conducted under this Act shall supplement, but not replace, research that is otherwise conducted or supported as part of the comprehensive pediatric research portfolio.
Requires consortia to conduct basic, clinical, behavioral, social, or translational research, as well as training in, and demonstration of, advanced diagnostic and treatment methods relating to pediatrics.
Requires the Director of NIH to: (1) provide for the coordination of information and ensure regular communication between consortia; and (2) require periodic reports on the activities of the consortia.
Requires each consortium under this Act to be formed from a collaboration of cooperating institutions with a lead institution, meeting requirements that may be prescribed by the Director of NIH.
Declares that payments made under this Act may be provided for a period of five years and extended for additional five-year periods with enhanced funding opportunities based on an appropriate scientific review of the operations.